C33T (p.Cys33Thr) variant of SGCD (Delta-sarcoglycan)
C33T (p.Cys33Thr) in SGCD (Delta-sarcoglycan) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
C33T (p.Cys33Thr) variant details
- p.Cys33Thr
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available